Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00367809
Other study ID # GCRC Protocol 942
Secondary ID
Status Completed
Phase Phase 3
First received August 21, 2006
Last updated September 12, 2008
Start date August 2003
Est. completion date May 2008

Study information

Verified date September 2008
Source National Institute of Nursing Research (NINR)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The Wellness Interventions after Transplant (WIAT) Trial has reached its enrollment target. This trial is no longer recruiting new patients. Those currently enrolled will be followed for a year to evaluate trial outcomes.

The purpose of this trial is to determine if training in Mindfulness-Based Stress Reduction can reduce symptom distress and improve quality of life in solid organ transplant recipients. Primary study outcomes are depression, anxiety and insomnia symptoms, measured by well-validated self-report scales. The impact of this program on objectively measured sleep outcomes, use of health care resources and costs will also be evaluated.


Description:

Pharmacologic options for managing symptoms increase the risks of side effects and drug interactions, and may reduce adherence by complicating an already challenging medication regimen. In contrast, mind-body based complementary therapies may be ideal to treat distressing symptoms and negative emotions after transplantation. Our long-range objective is to develop evidence-based recommendations for non-pharmacologic strategies that provide symptom relief to transplant recipients, and are safe, practical and cost-effective.

Potential participants are recruited by mail, screening by clinic staff and provider referrals. Interested persons are screened by telephone and mailed informational study brochures. Informed consent is conducted by face-to-face interview, where a diagram of the study design is used to explain the 2-stage randomization and study requirements.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date May 2008
Est. primary completion date May 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- kidney, kidney/pancreas, pancreas, lung, liver, heart or heart-lung recipients, with a functioning graft

- 18 years old or older

- English-speaking

- literate

- mentally intact

- reachable by telephone

- on immune suppressive medication

- receiving regular medical follow-up care

- interested in health promotion and mind-body interventions

- able to attend weekly classes in a Minnesota Metro area

- willing to complete the informed consent process

Exclusion Criteria:

- serious preexisting mental health issues such as suicide attempts or a psychosis

- medically unstable (a hospital admission for non-elective purposes in the last 3 months or major surgery planned in the next 3 months)

- on dialysis

- regularly practicing mindfulness meditation

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-Based Stress Reduction (MSBR)
Mindfulness-Based Stress Reduction (MBSR) is the intervention of primary interest. It is a psycho-educational program of 8-weekly classes, 2.5 hours long taught by a trained instructor. Over the course of the program participants receive training in several formal meditation techniques: a body-scan meditation, sitting meditation, walking meditation and mindful Hatha yoga that involves simple stretches and movements. Participants are requested to practice meditation at home and to integrate informal mindfulness practices into their daily lives. The content of MBSR is described in the book Full Catastrophe Living by Jon Kabat-Zinn.
Health Education (HE)
The active control condition was a peer-led chronic disease self-management program comprised of 8 weekly, 2.5 hour meetings. Led by trained peer-leaders, groups of participants discussed health challenges and problem-solved using a technique called action-planning. The curriculum described by Lorig and colleagues in the book Living a Health Life was the core of this program, and transplant-specific issues were covered in two meetings to match MBSR for time and attention.
Delayed Intervention
A temporary wait-list control group; after 6 months, those in the Delayed Intervention were randomized a second time, to one of the active treatment arms (MBSR or HE).

Locations

Country Name City State
United States University of Minnesota Academic Health Center Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Gross CR, Kreitzer MJ, Russas V, Treesak C, Frazier PA, Hertz MI. Mindfulness meditation to reduce symptoms after organ transplant: a pilot study. Altern Ther Health Med. 2004 May-Jun;10(3):58-66. — View Citation

Kreitzer MJ, Gross CR, Ye X, Russas V, Treesak C. Longitudinal impact of mindfulness meditation on illness burden in solid-organ transplant recipients. Prog Transplant. 2005 Jun;15(2):166-72. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in depression Baseline; at 8 weeks, at 6- and 12- months No
Primary anxiety Baseline; at 8 weeks, at 6- and 12- months No
Primary insomnia Baseline; at 8 weeks, at 6- and 12- months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03938324 - Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions N/A
Recruiting NCT05462041 - DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors N/A
Active, not recruiting NCT05194514 - Trial to Compare the SherpaPak™ Device vs Cold Storage N/A
Completed NCT02729142 - Bone Microarchitecture in the Transplant Patient N/A
Completed NCT00213265 - Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants Phase 3
Withdrawn NCT05157997 - Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail Phase 1
Not yet recruiting NCT05732922 - ORCHARD- Optimising Home Assessment of Rural Patients N/A
Recruiting NCT05595837 - Immune Registry for Organ Transplantation From COVID Positive Donors.
Completed NCT05194306 - PERTRIAL - Perla® Preservation Solution N/A
Recruiting NCT05884736 - Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant